Carolinas Wealth Consulting LLC Neurocrine Biosciences Inc Transaction History
Carolinas Wealth Consulting LLC
- $557 Million
- Q4 2024
A detailed history of Carolinas Wealth Consulting LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 10 shares of NBIX stock, worth $1,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10
Previous 6
66.67%
Holding current value
$1,072
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NBIX
# of Institutions
655Shares Held
96.6MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.52 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$524 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$323 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$272 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $10.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...